DePrince Race & Zollo Inc (DRZ)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-302,336
| Closed | -$40.9M | – | 200 |
|
|
2021
Q4 | $40.9M | Buy |
302,336
+41,577
| +16% | +$4.91M | 1.04% | 16 |
|
|
2021
Q3 | $28.1M | Sell |
260,759
-4,648
| -2% | -$531K | 0.75% | 47 |
|
|
2021
Q2 | $29.9M | Sell |
265,407
-9,065
| -3% | -$1.02M | 0.76% | 42 |
|
|
2021
Q1 | $29.7M | Buy |
274,472
+26,082
| +11% | +$2.79M | 0.8% | 32 |
|
|
2020
Q4 | $26.6M | Buy |
248,390
+36,340
| +17% | +$3.49M | 0.84% | 31 |
|
|
2020
Q3 | $18.6M | Buy |
212,050
+5,424
| +3% | +$511K | 0.7% | 51 |
|
|
2020
Q2 | $20.3M | Sell |
206,626
-3,041
| -1% | -$268K | 0.79% | 38 |
|
|
2020
Q1 | $16M | Sell |
209,667
-19,602
| -9% | -$1.67M | 0.73% | 49 |
|
|
2019
Q4 | $20.3M | Sell |
229,269
-31,030
| -12% | -$2.58M | 0.62% | 71 |
|
|
2019
Q3 | $19.7M | Buy |
260,299
+310
| +0.1% | +$21.3K | 0.57% | 90 |
|
|
2019
Q2 | $18.9M | Sell |
259,989
-3,180
| -1% | -$250K | 0.53% | 93 |
|
|
2019
Q1 | $21.2M | Buy |
263,169
+7,685
| +3% | +$629K | 0.58% | 71 |
|
|
2018
Q4 | $23.6M | Sell |
255,484
-4,930
| -2% | -$434K | 0.68% | 45 |
|
|
2018
Q3 | $24.6M | Buy |
260,414
+7,095
| +3% | +$673K | 0.55% | 76 |
|
|
2018
Q2 | $23.5M | Sell |
253,319
-13,950
| -5% | -$1.36M | 0.54% | 72 |
|
|
2018
Q1 | $25.3M | Sell |
267,269
-43,581
| -14% | -$4.79M | 0.59% | 71 |
|
|
2017
Q4 | $30.1M | Sell |
310,850
-43,177
| -12% | -$4.07M | 0.67% | 58 |
|
|
2017
Q3 | $31.5M | Sell |
354,027
-250,245
| -41% | -$19M | 0.71% | 49 |
|
|
2017
Q2 | $43.8M | Sell |
604,272
-53,041
| -8% | -$3.57M | 0.9% | 24 |
|
|
2017
Q1 | $42.8M | Sell |
657,313
-55,260
| -8% | -$3.47M | 0.88% | 23 |
|
|
2016
Q4 | $44.6M | Buy |
712,573
+35,615
| +5% | +$2.17M | 0.87% | 24 |
|
|
2016
Q3 | $42.7M | Sell |
676,958
-107,437
| -14% | -$6.96M | 0.9% | 26 |
|
|
2016
Q2 | $48.6M | Sell |
784,395
-63,302
| -7% | -$3.86M | 0.98% | 22 |
|
|
2016
Q1 | $48.4M | Sell |
847,697
-200,997
| -19% | -$11.2M | 0.97% | 23 |
|
|
2015
Q4 | $62.1M | Buy |
1,048,694
+102,811
| +11% | +$5.92M | 1.15% | 14 |
|
|
2015
Q3 | $51.5M | Sell |
945,883
-133,850
| -12% | -$8.71M | 0.92% | 26 |
|
|
2015
Q2 | $72.5M | Sell |
1,079,733
-202,670
| -16% | -$13.2M | 1.06% | 19 |
|
|
2015
Q1 | $75.1M | Buy |
1,282,403
+584,363
| +84% | +$35.3M | 1.06% | 18 |
|
|
2014
Q4 | $45.7M | Sell |
698,040
-70,850
| -9% | -$4.47M | 0.62% | 67 |
|
|
2014
Q3 | $44.4M | Sell |
768,890
-151,715
| -16% | -$8.42M | 0.6% | 71 |
|
|
2014
Q2 | $52M | Buy |
920,605
+4,080
| +0.4% | +$214K | 0.61% | 56 |
|
|
2014
Q1 | $47.1M | Buy |
916,525
+11,900
| +1% | +$601K | 0.56% | 74 |
|
|
2013
Q4 | $47.8M | Sell |
904,625
-71,750
| -7% | -$3.53M | 0.6% | 60 |
|
|
2013
Q3 | $43.7M | Sell |
976,375
-123,626
| -11% | -$5.48M | 0.59% | 68 |
|
|
2013
Q2 | $45.5M | Buy |
+1,100,001
| New | +$48.1M | 0.62% | 58 |
|
Other funds holding ABBV
DePrince Race & Zollo Inc (DRZ)'s ABBV Position: Q1 2022 in Review
DePrince Race & Zollo Inc (DRZ) sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 302,336 shares — an estimated $40.9M sold.
DePrince Race & Zollo Inc (DRZ) first reported a position in ABBV in Q2 2013 and held it in 35 quarters. The position peaked at $75.1M in Q1 2015. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- DePrince Race & Zollo Inc (DRZ) reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
- DePrince Race & Zollo Inc (DRZ) sold 302,336 AbbVie shares in Q1 2022, an estimated $40.9M.
- DePrince Race & Zollo Inc (DRZ) first reported a position in AbbVie in Q2 2013 and held it in 35 quarters.
- DePrince Race & Zollo Inc (DRZ)'s AbbVie position peaked at $75.1M in Q1 2015.
- 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q1 2022, filed 16 May 2022.